GGrantIndex
← Leaderboards

Marc Nathan Wein

Massachusetts General Hospital

$4,989,017
Attributed
$4,989,017
Total exposure
6
Grants
6
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $2.4M · FY201325
$2.5M$1.9M$1.3M$625K$0
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$9,710,345 · 7

By mechanism

P50$5,252,608 · 2
R01$3,317,633 · 1
K08$698,104 · 1
R03$337,870 · 2
F32$104,130 · 1

Top collaborators

No co-investigators on record.

Most similar at Massachusetts General Hospital

Same institution · by research overlap

Others in their field

Top investigators on “Bone

Research focus

BoneOsteoporosisOsteoblastsOsteocytesResponseOsteogenesisSkeletalBiologyAging PopulationCellsBone MassBone CellIn VitroGenesBone ResorptionIn VivoParathyroid Hormone ReceptorPathway InteractionsCostOsteoclastsMediatingMolecularPth GeneEquilibrium

Grant awards (26)

Center of Research Translation on Osteoporosis Bone Anabolic Therapies$1,392,115
P50 · FY2025 · AR · contact PI
The role of salt inducible kinases in parathyroid hormone action in bone$442,486
R01 · FY2025 · DK · contact PI
Admin Core$148,987
P50 · FY2025 · AR · contact PI
Center of Research Translation on Osteoporosis Bone Anabolic Therapies$1,637,497
P50 · FY2024 · AR · contact PI
The role of salt inducible kinases in parathyroid hormone action in bone$424,786
R01 · FY2024 · DK · contact PI
Admin Core$156,224
P50 · FY2024 · AR · contact PI
Center of Research Translation on Osteoporosis Bone Anabolic Therapies$1,691,716
P50 · FY2023 · AR · contact PI
The role of salt inducible kinases in parathyroid hormone action in bone$442,486
R01 · FY2023 · DK · contact PI
Admin Core$226,069
P50 · FY2023 · AR · contact PI
The role of salt inducible kinases in parathyroid hormone action in bone$401,575
R01 · FY2022 · DK · contact PI
The role of salt inducible kinases in parathyroid hormone action in bone$401,575
R01 · FY2021 · DK · contact PI
The role of salt inducible kinases in parathyroid hormone action in bone$401,575
R01 · FY2020 · DK · contact PI
The role of salt inducible kinases in parathyroid hormone action in bone$401,575
R01 · FY2019 · DK · contact PI
Reducing cartilage destruction in osteoarthritis with the small molecule SIK inhibitor YKL-05-099$83,596
R03 · FY2019 · AR · contact PI
Dissecting the roles of class IIa HDACs in osteocyte biology$71,568
K08 · FY2019 · AR · contact PI
The role of salt inducible kinases in parathyroid hormone action in bone$401,575
R01 · FY2018 · DK · contact PI
Dissecting the roles of class IIa HDACs in osteocyte biology$164,592
K08 · FY2018 · AR · contact PI
Skeletal effects of the small molecule SIK inhibitor YKL-05-099$85,339
R03 · FY2018 · AR · contact PI
Reducing cartilage destruction in osteoarthritis with the small molecule SIK inhibitor YKL-05-099$83,596
R03 · FY2018 · AR · contact PI
Dissecting the roles of class IIa HDACs in osteocyte biology$1,000
K08 · FY2018 · AR · contact PI
Dissecting the roles of class IIa HDACs in osteocyte biology$164,592
K08 · FY2017 · AR · contact PI
Skeletal effects of the small molecule SIK inhibitor YKL-05-099$85,339
R03 · FY2017 · AR · contact PI
Dissecting the roles of class IIa HDACs in osteocyte biology$164,592
K08 · FY2016 · AR · contact PI
Dissecting the roles of class IIa HDACs in osteocyte biology$131,760
K08 · FY2015 · AR · contact PI
The role of class II histone deacetylases in PTH signaling in osteocytes$44,698
F32 · FY2014 · DK · contact PI
The role of class II histone deacetylases in PTH signaling in osteocytes$59,432
F32 · FY2013 · DK · contact PI